4.0 Clinical Evaluation Prior to Treatment 
As described above, patients will be selected based on their 
past medical history and clinical course. Patients must have a 
confirmed HIV infection documented by Western blot analysis. The 
patients must meet the standard inclusion and exclusion criteria 
described above. In addition, the chosen patients must show no 
signs of active systemic infection or major cardiovascular or 
respiratory disease. The following laboratory values will be 
used as guidelines as enrollment: 
1. The bilirubin should be less than 2 mg/dl. 
2 . The platelet count should be greater than 
100,000/mm 3 . 
3. The white blood cell count should exceed 3,000/mm 3 . 
4. The creatinine should be less than 2.0 mg/dl. 
[141 
Recombinant DNA Research, Volume 18 
